A humanized system for pharmacologic control of gene expression

Nature Medicine

Volumn 2, Issue 9, 1996, Pages 1028-1032

  Rivera, Victor M ^a   Clackson, Tim ^a   Natesan, Sridakan ^a   Pollock, Roy ^a   Amara, Jane F ^a   Keenan, Terence ^a   Magari, Shannon R ^a   Phillips, Tom ^a   Courage, Nancy L ^a   Franklin Cerasoli, J R ^a   Holt, Dennis A ^a   Gilman, Michael ^a  

^a ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; RAPAMYCIN;

ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARRIER PROTEINS; CELL TRANSPLANTATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE THERAPY; GROWTH HORMONE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPHILINS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, NUDE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYENES; RECOMBINANT FUSION PROTEINS; SIROLIMUS; TACROLIMUS BINDING PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 9544226448     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0996-1028     Document Type: Article

References (39)

1. Gossen, M., Bonin, A. & Bujard, H Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biol. Sci. 18, 471-475 (1993).
2. Spencer, D.M Creating conditional mutants in mammals Trends Genet. 12, 181-187 (1996).
3. Ptashne, M. How eukaryotic transcriptional activators work. Nature 335, 683-689 (1988)
4. Brent, R. & Ptashne, M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor. Cell 43, 729-736 (1985).
5. Hope, I.A. & Struhl, K Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast. Cell 46, 885-894 (1986).
6. Fields, S. & Song, O.-K. A novel genetic system to detect protein-protein interactions. Nature 340, 245-246 (1989)
7. Spencer, D M., Wandless, T.J., Schreiber, S.L. & Crabtree, G.R Controlling signal transduction with synthetic ligands. Science 262, 1019-1024 (1993).
8. Austin, D.J , Crabtree, G.R. & Schreiber, S.L. Proximity versus allostery: The role of regulated protein dimerization in biology. Chem. Biol. 1, 131-136 (1994).
9. Pruschy, M.N. et al. Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012 Chem. Biol 1, 163-172 (1994).
10. Spencer, D M., Graef, I., Austin, D J., Schreiber, S.L. & Crabtree, G.R. A general strategy for producing conditional alleles of Src-like tyrosine kinases. Proc. Natl. Acad. Sci. USA 92, 9805-9809 (1995).
11. Holsinger, L.J., Spencer, D.M , Austin, D.J., Schreiber, S.L. & Crabtree, G.R. Signal transduction in T lymphocytes using a conditional allele of Sos Proc. Natl. Acad. Sci. USA 92, 9810-9814 (1995).
12. Belshaw, P.J , Ho, S.N , Crabtree, G.R & Schreiber, S.L. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl. Acad. Sci. USA 93, 4604-4607 (1996).
13. Ho, S N., Biggar, S.R., Spencer, D M., Schreiber, S.L & Crabtree, G.R Controlling transcription with synthetic ligands. Nature (in the press).
14. Bierer, B.E. et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin Proc. Natl. Acad. Sci. USA 87, 9231-9235 (1990)
15. Brown, E.J. et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758 (1994).
16. Chiu, M I , Katz, H. & Berlin, V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex Proc. Natl. Acad. Sci. USA 91, 12574-12578 (1994).
17. Sabatini, D.M , Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S H RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35-43 (1994)
18. Sabers, C.J. et al. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells J. Biol. Chem. 270, 815-822 (1995)
19. Stan, R. et al. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue J Biol. Chem. 269, 32037-32030 (1994).
20. Kahan, B., Chang, J & Sehgal, S. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation 52, 185-191 (1991).
21. Kay, J., Kromwel, L., Doe, S. & Denyer, M Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology 72, 544-549 (1991)
22. Stepkowski, S., Chen, H., Daloze, P & Kahan, B. Rapamycin, apotent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 51, 22-26 (1991)
23. Pomerantz, J L., Sharp, P.A. & Pabo, C O Structure-based design of transcription factors. Science 267, 93-96 (1995)
24. Schmitz, M.L & Baeurle, P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-κB EMBO J. 10, 3805-3817 (1991).
25. Chen, J., Zheng, X F , Brown, E J. & Schreiber, S.L. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc Natl Acad. Sci USA 92, 4947-4951 (1995).
26. Heartlein, M.W. et al. Long-term production and delivery of human growth hormone. Proc. Natl. Acad Sci USA 91, 10967-10971 (1994).
27. Riddell, S.R et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med. 2, 216-223 (1996).
28. Stern, L J. & Wiley, D.C. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2, 245-251 (1994)
29. Luengo, J.I. et al. Structure-activity studies of rapamycin analogs: Evidence that the C-7 methoxy is part of the effector domain and positioned at the FKBP12/FRAP interface. Chem. Biol. 2, 471-481 (1995)
30. Belshaw, P.J., Schoepfer, J., Liu, K., Morrison, K & Schreiber, S.L. Rational design of orthogonal receptor-ligand combinations. Angew. Chem. Int. Ed. Eng. 34, 2129-2132 (1995).
31. Choi, J., Chen, J., Schreiber, S L & Clardy, J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP Science 273, 239-242 (1996).
32. Attar, R.M. & Gilman, M Z. Expression cloning of a novel zinc-finger protein that binds to the c-fos serum response element Mol. Cell. Biol. 12, 2432-2443 (1992).
33. Standaert, R.F., Galat, A., Verdine, G.L & Schreiber, S.L. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature 346, 671-674 (1990).
34. Boshart, M. et al. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41, 521-530 (1985)
35. Siebenlist, U et al. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells Mol. Cell. Biol. 6, 3042-3049 (1986).
36. Selden, R.F., Burke-Howie, K., Rowe, M.E., Goodman, H M. & Moore, D.D Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6, 3173-3179 (1986).
37. Morgenstern, J P. & Land, H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596 (1990).
38. Muller, A.J. et al. BCR first exon sequences specifically activate BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias Mol. Cell. Biol. 11, 1785-1792 (1991).
39. Pear, W S , Nolan, G.P., Scott, M.L & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection Proc. Natl. Acad. Sci. USA 90, 8392-8396 (1993).